Feasibility of iNKT cell and PD-1+CD8+ T cell-based immunotherapy in patients with lung adenocarcinoma: Preliminary results of a phase I/II clinical trial-Reference-Cited by-同舟云学术

Feasibility of iNKT cell and PD-1+CD8+ T cell-based immunotherapy in patients with lung adenocarcinoma: Preliminary results of a phase I/II clinical trial

Published:2022-05 Issue: Volume:238 Page:108992
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Cheng Xiaobo,Wang Jing,Qiu Chenli,Jin Yanling,Xia Bili,Qin Ran,Hu Huiliang,Yan Jia,Zhang Xiaoyan,Xu Jianqing

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference25 articles.

1. Therapeutic management options for stage III non-small cell lung cancer;Yoon;World J. Clin. Oncol.,2017

2. Multinational randomized phase III trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non-small-cell lung cancer: KCSG-LU05-04;Ahn;J. Clin. Oncol.,2015

3. Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors;Song;Sci. Rep.,2019

4. Chimeric antigen receptor T-cell (CAR T) therapy for hematologic and solid malignancies: efficacy and safety-a systematic review with meta-analysis;Yu;Cancers (Basel),2019

5. Corrigendum: chimeric antigen receptors T cell therapy in solid tumor: challenges and clinical applications;Mirzaei;Front. Immunol.,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy;Frontiers in Immunology;2024-08-19

2. Traversing the bench to bedside journey for iNKT cell therapies;Frontiers in Immunology;2024-08-07

3. Bona fidecytotoxic iNKT cells with superior antitumour responses identified in mice and humans;2024-07-22

4. Advances in understanding immune homeostasis in latent tuberculosis infection;WIREs Mechanisms of Disease;2024-02-13

5. Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023);World Journal of Gastroenterology;2023-10-28